Document Detail


Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.
MedLine Citation:
PMID:  21124769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We demonstrated previously that the incorporation of a membrane-anchored form of flagellin into influenza virus-like particles (VLPs) improved the immunogenicity of VLPs significantly, inducing partially protective heterosubtypic immunity by intramuscular immunization. Because the efficacy of mucosal vaccination is highly dependent on an adjuvant, and is particularly effective for preventing mucosal infections such as influenza, we determined whether the membrane-anchored flagellin is an efficient adjuvant for VLP vaccines by a mucosal immunization route. We compared the adjuvant effect of membrane-anchored and soluble flagellins for immunization with influenza A/PR8 (H1N1) VLPs by the intranasal route in a mouse model. The results demonstrate that membrane-anchored flagellin is an effective adjuvant for intranasal (IN) immunization, inducing enhanced systemic and mucosal antibody responses. High cellular responses were also observed as shown by cytokine production in splenocyte cultures when stimulated with viral antigens. All mice immunized with flagellin-containing VLPs survived challenge with a high lethal dose of homologous virus as well as a high dose heterosubtypic virus challenge (40 LD(50) of A/Philippines/82, H3N2). In contrast, no protection was observed with a standard HA/M1 VLP group upon heterosubtypic challenge. Soluble flagellin exhibited a moderate adjuvant effect when co-administered with VLPs by the mucosal route, as indicated by enhanced systemic and mucosal responses and partial heterosubtypic protection. The membrane-anchored form of flagellin incorporated together with antigen into influenza VLPs is effective as an adjuvant by the mucosal route and unlike standard VLPs, immunization with such chimeric VLPs elicits protective immunity to challenge with a distantly related influenza A virus.
Authors:
Bao-Zhong Wang; Rui Xu; Fu-Shi Quan; Sang-Moo Kang; Li Wang; Richard W Compans
Related Documents :
21424379 - The role of polymorphisms in toll-like receptors and their associated intracellular sig...
21430049 - Genome-scale evolution and phylodynamics of equine h3n8 influenza a virus.
21334259 - Development of vaccines against tuberculosis.
21411599 - Successful memory response following a booster dose with a virosome-formulated hepatiti...
21354949 - Abundance of ifn-α and ifn-γ gene transcripts and absence of il-2 transcripts in the ...
21123189 - A novel sequence-based antigenic distance measure for h1n1, with application to vaccine...
8856349 - Pathogenesis of infection with varicella vaccine.
18840319 - Household structure and infectious disease transmission.
3117729 - Superiority of the chimpanzee animal model to study the pathogenicity of known mycoplas...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-11-29
Journal Detail:
Title:  PloS one     Volume:  5     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2010  
Date Detail:
Created Date:  2010-12-02     Completed Date:  2011-04-27     Revised Date:  2013-03-05    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e13972     Citation Subset:  IM    
Affiliation:
Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Animals
Antibodies, Viral / blood,  immunology
Cell Line
Cell Membrane / metabolism
Chick Embryo
Flagellin / genetics,  immunology*,  metabolism
Hemagglutination Tests
Immunity, Mucosal / drug effects,  immunology
Immunization / methods
Influenza A Virus, H1N1 Subtype / genetics,  immunology
Influenza A Virus, H3N2 Subtype / genetics,  immunology
Influenza Vaccines / administration & dosage,  immunology*
Interferon-gamma / metabolism
Interleukin-4 / metabolism
Mice
Neutralization Tests
Orthomyxoviridae Infections / immunology*,  prevention & control,  virology
Spodoptera
T-Lymphocytes / drug effects,  immunology,  metabolism
Virion / genetics,  immunology*
Grant Support
ID/Acronym/Agency:
AI068003/AI/NIAID NIH HHS; AI074579/AI/NIAID NIH HHS; R01 AI068003-01/AI/NIAID NIH HHS; U01 AI074579-01/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Viral; 0/Influenza Vaccines; 12777-81-0/Flagellin; 207137-56-2/Interleukin-4; 82115-62-6/Interferon-gamma
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Child...
Next Document:  Study of bioengineered zebra fish olfactory receptor 131-2: receptor purification and secondary stru...